inositol 2,4,5-trisphosphate has been researched along with bicalutamide in 1 studies
Studies (inositol 2,4,5-trisphosphate) | Trials (inositol 2,4,5-trisphosphate) | Recent Studies (post-2010) (inositol 2,4,5-trisphosphate) | Studies (bicalutamide) | Trials (bicalutamide) | Recent Studies (post-2010) (bicalutamide) |
---|---|---|---|---|---|
40 | 0 | 3 | 1,313 | 212 | 541 |
Protein | Taxonomy | inositol 2,4,5-trisphosphate (IC50) | bicalutamide (IC50) |
---|---|---|---|
Progesterone receptor | Oryctolagus cuniculus (rabbit) | 5.6 | |
Progesterone receptor | Homo sapiens (human) | 1.819 | |
Androgen receptor | Homo sapiens (human) | 0.404 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.7168 | |
Androgen receptor | Mus musculus (house mouse) | 1.835 | |
Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | 0.12 | |
Progesterone receptor | Rattus norvegicus (Norway rat) | 0.89 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Prevarskaya, N; Roudbaraki, M; Shuba, Y; Skryma, R; Vanden Abeele, F | 1 |
1 other study(ies) available for inositol 2,4,5-trisphosphate and bicalutamide
Article | Year |
---|---|
Store-operated Ca2+ current in prostate cancer epithelial cells. Role of endogenous Ca2+ transporter type 1.
Topics: Androgen Antagonists; Anilides; Calcium; Calcium Channels; Endoplasmic Reticulum; Epithelial Cells; Humans; Inositol Phosphates; Kinetics; Male; Nitriles; Oligonucleotides, Antisense; Patch-Clamp Techniques; Prostatic Neoplasms; RNA, Messenger; Tosyl Compounds; TRPV Cation Channels; Tumor Cells, Cultured | 2003 |